NSAID treatment suppresses VSV propagation in mouse CNS

Virology

Volumn 276, Issue 1, 2000, Pages 44-51

  Chen, Nannan ^a   Warner, Jennifer L ^b   Reiss, Carol Shoshkes ^a  

^a NEW YORK UNIVERSITY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DRUG MECHANISM; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS; VIRUS ENCEPHALITIS;

EID: 0034633794     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0562     Document Type: Article

References (53)

1. Immunological NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
2. Induction of cyclooxygenase and nitric oxide synthase in inflammation
3. HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclo-oxygenase type 2 (COX-2)
4. 3 in the rat lumbar spinal cord
5. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
6. Inhibition of vesicular stomatitis virus infection by nitric oxide
7. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity
8. Prostaglandin levels in cerebrospinal fluid from multiple sclerosis patients in remission and relapse
9. Nitric oxide mediates glutamate linked enhancement of cGMP levels in the cerebellum
10. LPS injected into the cerebral ventricle evokes fever through induction of COX-2 in brain endothelial cells
11. Nitric Oxide Synthase/COX cross-talk: Nitric oxide activates COX-1 but inhibits COX-2 derived prostaglandin production
12. COX-1 and COX-2 expression: Implication and predictions
13. Cox-1 B2 are differentially localized to microglia and endothelium in rat EAE and glioma
14. Prostaglandin E synthesis in patients with multiple sclerosis: Correlation with disease activity
15. Cyclooxygenase in biology and disease
16. Production of prostaglandin E and interleukin-1 like factor by cultured astrocytes and C6 glioma cells
17. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia
18. Synergy between Cox induction and aracadonic acid supply in vivo: Consequences of NSAID efficacy
19. Prostanoids inhibit Kupffer cell nitric oxide synthesis
20. Gamma interferon-induced nitric oxide-mediated inhibition of vaccinia virus replication
21. Phorbol diester TPA elicits prostaglandin E release from cultured rat astrocytes
22. Interferon-gamma reduces cyclooxygenase-2-mediated prostaglandin E2 production from primary mouse astrocytes independent of nitric oxide formation
23. Local nitric oxide production in viral and autoimmune diseases of the central nervous system
24. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
25. Impaired blood-brain barrier function in angiotensinogen-deficient mice
26. Nitric Oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin
27. Inhibition of viral replication by interferon-gamma induced nitric oxide synthase
28. IL-12 and viral infections
29. Neuronal expression of NOS-1 is required for host recovery from viral encephalitis
30. Mechanisms of NO inhibition of viral replication
31. IFN-gamma induced Type 1 nitric oxide inhibits viral replication in neurons
32. Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: A possible mechanism to polarize Th2 type response in BALB/c mice
33. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric-oxide mediated mechanism
34. 2 in macrophages: Distinct susceptibility in murine J774 and RAW 264.7 macrophages Prostag
35. Nitric oxide synthase: Aspects concerning structure and catalysis
36. Systemic biosynthesis of prostacyclin by Cox-2 the human pharmacology of a selective inhibitor of COX-2
37. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen
38. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia
39. Clinical acute renal failure with nonsteroidal anti-inflammatory drugs
40. The earliest events in VSV infection of the murine olfactory neuroepithelium and entry of the central nervous system
41. Minireview: Does nitric oxide play a critical role in viral infections?
42. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes involvement of interferon gamma and CD8+ T cells
43. 2 differentially modulates cytokine secretion profiles of human T helper Lymphocytes
44. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells
45. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania Major
46. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis
47. Co-induction of nitric oxide synthase and cyclooxygenase: Interactions between nitric oxide and prostanoids
48. Non-steroidal anti-inflammatory drug-induced gastric damage in experimental animals: Underlying pathological mechanisms
49. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
50. Rhabdovirus biology and infection: An overview
51. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness
52. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
53. The effects of nonsteroidal anti-inflammatory drugs on renal function: Experimental studies in animals